Chrysanthemum indicum Linné has been used in traditional medicine to treat various inflammatory diseases in East Asia. The aim of the present study was to investigate the protective effect of C. indicum ethanol extract (CILE) against cisplatin-induced nephrotoxicity. An HPLC-photodiode array method was used for fingerprint analysis of the CILE and ten major constituents were quantitatively analyzed. The protective effect of CILE on cisplatin-induced nephrotoxicity was assessed using both in vitro (porcine kidney cell; PK15 cell) and in vivo (Sprague Dawley rat) experiments. In the in vitro study, CILE enhanced PK15 cell viability after cisplatin treatment with recovered antioxidant status. Moreover, the increased p53 expression after cisplatin treatment was decreased in the CILE pretreated cells. In the in vivo study, SD rats were treated for 28 consecutive days with CILE (0, 100, 300 and 500 mg/kg). On day 23, a single dose of cisplatin (5 mg/kg) was injected to induce nephrotoxicity. The CILE pretreated group showed recovered serum renal function index with ameliorated oxidative stress. Histopathological alterations and apoptosis in the kidney were also decreased in CILE pretreated rats. Taken together, CILE could attenuate cisplatin-induced nephrotoxicity and might be a beneficial agent for acute renal failure management.
Over the past two decades, although the pathophysiology has been studied of acute renal failure (ARF), its incidence rate and mortality are still rising [1] . It is well known that ARF-induced damage generates reactive oxygen species and the altered anti-oxidant status can lead to further damage in the renal system [2] .
Cisplatin (cis-Diammineplatinum Ⅱ dichloride, CDDP) is a platinum-containing anticancer drug, which is widely used against many types of solid tumor [3] . Despite its potency, dose related nephrotoxicity is the major side effect, which limits its clinical use [4] . Under pathological conditions, cisplatin activates multiple signaling pathways, resulting in necrosis and apoptosis of renal tubular cells [5] . Protein synthesis inhibition and glutathione depletion have been recognized as pathophysiological mechanisms of cellular damage by cisplatin [6] . Moreover, much evidence has revealed that this nephrotoxicity is closely related to reactive oxygen species (ROS), which cause mitochondrial damage, membrane transport protein inhibition and lipid peroxidation [7] . In this aspect, reduction of oxidative stress is considered as an important key in cisplatin-induced nephrotoxicity. Recently, many studies have focused on traditional herbal medicines as novel therapeutic agent against ARF and various natural compounds were found to have a protective effect against cisplatin-induced nephrotoxicity [8] [9] [10] .
Chrysanthemum indicum Linné, a perennial herbaceous plant, has been used as a tonic in traditional medicine against various disease conditions, such as dizziness, inflammation, fever, and hypertension in East Asia [11] . C. indicum was found to contain various phytochemicals, such as flavonoids, terpenoids, phenolic compounds and essential oils, as well as glucosides [12] . Previous studies have revealed that C. indicum exhibits anti-bacterial, antiviral, anti-oxidant, and anti-inflammatory properties [13] [14] [15] . An ethanol extract of C. indicum decreased dimethylbenzene-induced auricle edema in mice, together with immunomodulatory activities [16] . Furthermore, it was reported recently that C. indicum reduces cisplatin-induced apoptosis in human proximal tubular HK-2 cells [17] .
The present study was undertaken to explore the protective effect of C. indicum ethanol extract (CILE) against a cisplatin-induced nephrotoxicity model using both in vitro and in vivo models. Standardization of the CILE was achieved by using an HPLCphotodiode array (PDA) method. The method was simple, rapid and convenient for simultaneous determination of four phenolic acids (1-3, 5) and six flavonoids (4, 6-10) in CILE ( Figure 1 ). Reproducibility was assessed by repeatedly measuring retention times and peak areas for six independently prepared samples. Reproducibility of compounds (1-10) was less than RSD (relative standard deviations) 1.5% for peak responses, and less than RSD 0.3% for retention times (data not shown). The correlation coefficients (r 2 ) of the calibration curves for three constituents were ≥ 0.9999. The contents of compounds (1-10) identified in CILE were 0.02-1.24 mg/g and these results are summarized in Table 1 . Among the 10 major constituents, the content of 3,5dicaffeoylquinic acid was relatively abundant in CILE. Previously, dicaffeoylquinic acid was reported to have an anti-hepatitis B virus effect along with anti-oxidative and anti-inflammatory properties [18] . Moreover, other constituents of CILE, including chlorogenic acid, luteolin, apigenin and acacetin were also reported to have various biological effects, including anti-oxidant [19] [20] [21] [22] . In the in vitro study, the effect of CILE on cisplatin-induced nephrotoxicity was assessed using porcine kidney (PK15) cells. The viability of PK15 cells after cisplatin treatment was assessed by crystal violet assay, which measures the number of viable adherent cells. CILE treatment showed maximum viability in the 50 µg/mL treated cells. However, the 200 µg/mL of CILE showed markedly decreased viability (15%) when compared with the control cells ( Figure 2A ). After determining the dose range, the protective effect of CILE against cisplatin-induced cytotoxicity in PK15 cells was assessed by crystal violet assay ( Figure 2B ). The cisplatin alone treated cells showed decreased viability (52%). Ascorbic acid (positive control) pretreatment increased the viability value to almost that of the control cells, and CILE also enhanced viability by up to 72% (p < 0.05) at 50 µg/mL. Glutathione (GSH) and ROS levels in PK15 cells after cisplatin treatment were monitored ( Figures 3A and B ). GSH is an antioxidant, which prevents damage by reactive oxygen species and chemically reactive toxic compounds [23] . In cisplatin-induced nephrotoxicity, platinum-GSH conjugates formed in cells were metabolized to a reactive thiol, which is a potent nephrotoxin, and depleted GSH impairs regulation of reactive oxygen species (ROS) [24] . In the present study, the CILE pretreated cells showed enhanced antioxidant marker (GSH) with lowered oxidative stress marker (ROS) when compared with cisplatin alone treated cell. The GSH content was decreased after cisplatin exposure (82% of control). However, decreased GSH content was markedly enhanced in the CILE pretreated cell (121% of control; p < 0.05). In contrast, the increased ROS level (146% of control) after cisplatin treatment was slightly reduced to 136% of control after 50 µg/mL CILE treatment (p < 0.05). In this study, the effect of CILE on p53 expression in PK15 cell was assessed using Western-blot analysis. CILE pretreatment decreased over-expressed p53 after cisplatin treatment ( Figure 3C ; p < 0.05).
The most important function of p53 is its ability to activate apoptosis, which is stimulated by several factors, including oxidative stress [25, 26] . Oxidative stress can activate an array of signaling pathways involving various protein kinases to result in p53 phosphorylation and activation, which may participate apoptosis cascades [27, 28] . In the present study, elevated p53 expression after cisplatin treatment was decreased in the CILE pretreated cells. Furthermore, decreased apoptotic cells were found in the terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining from the in vivo study. Moreover, Cheon et al. [29] reported that C. indicum extract inhibits the lipopolysaccharide-induced inflammatory response by suppressing nuclear factor kappa B (NF-κB) activation [29] . It was previously revealed that activation of NF-κB leads to expression of many genes involved in renal damage such as inducible nitric oxide synthase (iNOS), the pro-inflammatory cytokine gene, and reduced NF-κB, followed by reduced renal damage [30, 31] .
In the in vivo study, the protective effect of CILE against a single dose of ciplatin-induced ARF was assessed using a rat model. No adverse effects were observed in any of the animals during 28 days of consecutive oral administration of CILE. The levels of blood urea nitrogen (BUN) and serum creatinine (CRE) in the cisplatin alone group were significantly increased to 82.8±9.0 and 6.9±1.2 mg/dL ( in line with the present in vitro study ( Table 2 ). Cisplatin treatment markedly increased the kidney lipid peroxidation (malondialdehyde, MDA) level, whereas the GSH level was significantly decreased if compared with the control (p < 0.05). In the captopril treated group, the elevated MDA level was significantly decreased and GSH content recovered when compared with the cisplatin alone group. In the CILE treated groups, the MDA level was decreased in the 500 mg/kg treated group, which is about 30% of that of the cisplatin alone group, together with increased GSH content. The protective effect of CILE against cisplatin-induced ARF was confirmed by histopathological examination. In general, cisplatin accumulates in the S3 segment of the proximal tubule and produces broad damage in the specific S3 segment [32, 33] . In the present control group, the kidney showed normal morphology with wellpreserved brush border membranes ( Figure 4A ). In the cisplatin alone treated kidney, severe renal tubular changes were observed, including proximal tubular necrosis, desquamation and parenchymal degeneration ( Figure 4B ). The pathological alteration was ameliorated in the CILE pretreated group, although, minimal to mild dilated tubules, slight desquamation and tubular epithelial cell atrophy were still observed ( Figures 4D-F ).
In addition, cisplatin-induced apoptosis in kidney tissues was also detected using TUNEL staining ( Figure 5 ). The positive stained nucleus was observed in the proximal tubule cells in the cisplatin treated groups. The increase in the TUNEL-positive cells was reduced in all CILE pretreated groups when compared with the cisplatin alone treated group, in a dose dependent manner (p < 0.05).
In the present study, the protective effect of the CILE against cisplatin-induced toxicity was assessed using both in vitro and in vivo assay. Pretreatment with CILE showed recovered antioxidant status with down-regulated p53 expression in cisplatin treated PK15 cells. In addition, 4 weeks of CILE pretreatment ameliorated renal damage and enhanced antioxidant status, together with decreased apoptosis. Taken together, CILE might be beneficial in preventing ARF incidences, although further studies are required prior to clinical application.
Experimental
General: The analytical sample of C. indicum was purchased from Omniherb (Yeongcheon). The origin of the sample was confirmed taxonomically by Professor Je-Hyun Lee, Dongguk University (Gyeongju). A voucher specimen (No. KIOM-S8) has been deposited at the Basic Herbal Medicine Research Group, Korea 
CILE and standard solution preparation:
Dried C. indicum (200 g) was extracted with 70% ethanol (2 L × 3 times) by shaking in an incubator for 1 h. The extract was filtered through filter paper, evaporated and freeze-dried (41.4 g). The yield of ethanol extract obtained was 20.7%. To prepare a sample for HPLC analysis, a lyophilized sample (30 mg) was dissolved in 70% ethanol (10 mL) and mixed. The solution was filtered through a SmartPor GHP syringe filter (0.2 μm pore size, Woongki Science, Seoul, Korea). The stock solutions of reference standards, including chlorogenic acid, 4-hydroxybenzoic acid, caffeic acid, 3,5-dicaffeoylquinic acid, apigenin7-O-glucoside, eriodicytoyl, luteolin and apigenin (all at 1000 μg/mL) were prepared in methanol, and acacetin (900 μg/mL) and luteolin7-O-glucoside (500 μg/mL) were dissolved in 10% DMSO (in methanol). All stock solutions were stored below 4°C. Working standard solutions were prepared by serial dilution of stock solutions with methanol.
HPLC conditions:
A Shimadzu LC-20A HPLC system (Shimadzu Co., Kyoto, Japan) consisting of a solvent delivery unit, an on-line degasser, a column oven, an auto-sampler, and a PDA detector was employed. The data processor used LC Solution software (Version 1.24; Shimadzu Co., Kyoto, Japan). The analytical column for separation used was a Gemini C18 column (250 × 4.6 mm; particle size 5 μm; Phenomenex, Torrance, CA, USA) maintained at 40°C. The mobile phases for chromatographic separation were used by gradient elution of solvent A (1.0%, v/v, aqueous acetic acid) and solvent B (1.0%, v/v, acetic acid in acetonitrile). The gradient flow was programmed as follows; 5% B (5 min), 5-70% B (30 min), 70-100% B (45 min), 100% B (50 min), 100-5% B (55 min) and 100% B (70 min). Analysis was performed at a flow-rate of 1.0 mL/min with detection wavelengths of 254 and 280 nm. The injection volume was 10 μL. All calibration curves were obtained by assessment of peak areas of standard solutions in the concentration ranges of 0.14-18.00 μg/mL (acacetin), 0.16-20.00 μg/mL (4hydroxybenzoic acid, caffeic acid, eriodictyol, luteolin and apigenin) and 0.78-100.00 μg/mL (chlorogenic acid, luteolin7-Oglucoside and apigenin7-O-glucoside). The limits of detection (LOD) and of quantification (LOQ) for data obtained under the chromatographic conditions used in the present study were determined using signal-to-noise (S/N) ratios of 3 and 10, respectively.
Cell culture and treatment: PK15 cells (Korea Cell Line Bank, Seoul, Korea) were maintained as a monolayer culture in Dulbecco's modified eagle medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (FBS), penicillin (100 U/mL) and streptomycin (100 mg/mL) in humidified air with 5% CO 2 at 37°C. Cells were fed with fresh medium at 48 h intervals. For all assays, the cells were seeded at a density of 1 × 10 4 cells/mL in 96-well plates in the regular growth medium, and the experiments were carried out on the following day.
Cell viability assay:
Cytotoxicity of CILE on PK15 cells was determined prior to assessment of the effect of CILE on cisplatin treated PK15 cells. Serial concentrations of CILE (0, 10, 20, 50, 100 and 200 µg/mL) were treated for 24 h and the viability of PK15 cells was assessed using MTT assay. The MTT assay was performed using an EZ-Cytox Cell Viability assay kit according to the manufacturer's protocol. The MTT reduction was measured at a 450 nm wavelength using a micro-plate reader. The protective effect of CILE against cisplatin toxicity in PK15 cell was assessed using crystal violet assay. The CILE (0, 10, 20 and 50 µg/ml) was treated 2 h prior to cisplatin (25 µg/mL) treatment. After cisplatin treatment, all cells were incubated for 24 h before assay. Untreated cells were used as a control group. The crystal violet assay was carried out based on the previous report and the results were expressed as viability rate, with respect to the control [34] .
ROS and GSH levels in PK15 cell:
For ROS and GSH assays, the cells were pretreated with ascorbic acid (positive control, 1.7 mg/mL) and CILE (0 and 50 µg/mL) 2 h before cisplatin (25 µg/mL) treatment and incubated for 24 h. The level of ROS in PK15 cells was determined by DCFH-DA. After 24 h incubation, the PK15 cells were treated with 10 μM DCFH-DA for an additional 5 h. The fluorescence produced by oxidized DCFH was measured using a microplate reader at 485 and 528 nm for excitation and emission wavelengths, respectively. The GSH level was determined by the improved DTNB [5,50-dithiobis-(2nitrobenzoic acid)] method using a commercial GSH assay kit according to the manufacturer's protocol.
Western blot assay: PK15 cells were treated in the same manner as for the ROS and GSH assay. After incubation, the cells were lysed with lysis buffer (20 mM Tris-HCl pH 8, 150 mM NaCl) containing a protease inhibitor cocktail. After the bovine serum albumin protein assay, 30 µg of protein was separated using 12% SDS-PAGE. The proteins were transferred onto a nitrocellulose membrane in a Semi-Dry Transfer system from Bio-Rad (Hercules). The membrane was blocked with 5%, w/v, dry milk in 1× TBS with 20% TWEEN-20 (TBS-T) and incubated with anti-p53 primary antibody (1:300, Santa Cruz). Horseradish peroxidase-conjugated anti-mouse IgG (1:5000, Santa Cruz) was used for detection of p53.
Immunoreactivity was visualized using an enhanced chemiluminescence detection (ECL) kit (Amersham Pharmacia Biotech).
Animal treatment:
Male Sprague Dawley (SD) rats, 5-6 weeks old, were obtained from Orient Bio (Seongnam, Korea) and acclimated to the laboratory conditions (25 ± 0.2 °C, 50% relative humidity and 12 h light/dark cycle) for 1 week before the experiments. All animals were supplied with standard chow (Charles River Inc., Richmond, IN) and water ad libitum. Healthy SD rats (n = 36) were randomly allocated into 6 groups (n = 6/group) as follows: group 1 (control), group 2 (100 mg/kg of captopril, followed by cisplatin injection), group 3-6 (0, 100, 300 and 500 mg/kg of CILE, followed by cisplatin injection). CILE was prepared in distilled water and all animals were administered 5 mL/kg of body weight. Control and cisplatin alone groups were orally administered with distilled water and the others were orally administered with captopril (100 mg/kg)
